Universal Health (UHS) analyst forecast and price target
Analyst forecast
Consensus of 23 analyst ratings
Based on 9 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Sector Perform | $183.00 | Aug 20, 2026 |
| RBC Capital | Maintained | Sector Perform | $183.00 from $190.00 | Aug 3, 2026 |
| Goldman Sachs | Maintained | Neutral | $190.00 from $242.00 | Jul 30, 2026 |
| Baird | Maintained | Neutral | $166.00 from $204.00 | Jul 29, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $194.00 | Jul 29, 2026 |
| Guggenheim | Maintained | Buy | $189.00 from $195.00 | Jul 29, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $191.00 from $212.00 | Jul 29, 2026 |
| Barclays | Maintained | Equal-Weight | $168.00 from $179.00 | Jul 28, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $194.00 | Jul 28, 2026 |
| Guggenheim | Maintained | Buy | $195.00 from $211.00 | Jul 20, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $166.00 from $165.00 | Jul 13, 2026 |
| Barclays | Downgraded | Overweight → Equal-Weight | $179.00 | Jul 8, 2026 |
| TD Cowen | Maintained | Buy | $197.00 from $230.00 | Jun 22, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $165.00 | Jun 1, 2026 |
| UBS | Maintained | Buy | $310.00 from $320.00 | Apr 30, 2026 |
| Baird | Maintained | Neutral | $204.00 from $241.00 | Apr 29, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $194.00 from $229.00 | Apr 29, 2026 |
| Guggenheim | Maintained | Buy | $211.00 from $238.00 | Apr 29, 2026 |
| RBC Capital | Maintained | Sector Performer → Sector Perform | $190.00 from $216.00 | Apr 29, 2026 |
| TD Cowen | Maintained | Buy | $230.00 from $245.00 | Apr 29, 2026 |
Frequently asked questions
What is the price target for UHS stock?
The average 12-month analyst price target for Universal Health (UHS) is $182.67, with a high estimate of $197.00 and a low of $166.00, across 9 analysts.
Is UHS a buy, sell, or hold?
Analysts covering Universal Health currently average a Hold rating: 8 buy, 14 hold and 1 sell, from 23 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for UHS?
The average price target of $182.67 implies 5.90% upside from the last price of $172.49.
What is the latest analyst rating on UHS?
On Aug 20, 2026, RBC Capital maintained Universal Health at Sector Perform with a price target of $183.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.